Replimune (REPL) Equity Average (2018 - 2025)
Replimune has reported Equity Average over the past 8 years, most recently at $236.9 million for Q4 2025.
- Quarterly results put Equity Average at $236.9 million for Q4 2025, down 45.14% from a year ago — trailing twelve months through Dec 2025 was $236.9 million (down 45.14% YoY), and the annual figure for FY2025 was $395.2 million, down 15.0%.
- Equity Average reached $236.9 million in Q4 2025 per REPL's latest filing, down from $300.0 million in the prior quarter.
- Across five years, Equity Average topped out at $575.3 million in Q1 2023 and bottomed at $236.9 million in Q4 2025.
- Median Equity Average over the past 5 years was $437.6 million (2023), compared with a mean of $433.7 million.
- The largest annual shift saw Equity Average skyrocketed 166.19% in 2021 before it crashed 45.14% in 2025.
- Over 5 years, Equity Average stood at $447.5 million in 2021, then grew by 9.44% to $489.7 million in 2022, then fell by 9.47% to $443.4 million in 2023, then fell by 2.58% to $431.9 million in 2024, then plummeted by 45.14% to $236.9 million in 2025.
- Business Quant data shows Equity Average for REPL at $236.9 million in Q4 2025, $300.0 million in Q3 2025, and $376.3 million in Q2 2025.